FILE PHOTO: Doses of Bavarian Nordic’s Imvanex vaccine, used to protect against mpox virus, at the Edison municipal vaccination centre in Paris, France July 27, 2022. Alain Jocard/Pool via REUTERS/File Photo
FILE PHOTO: Doses of Bavarian Nordic’s Imvanex vaccine, used to protect against mpox virus, at the Edison municipal vaccination centre in Paris, France July 27, 2022. Alain Jocard/Pool via REUTERS/File Photo